Aromatase inhibitors in the treatment of severe endometriosis

Obstetrics and Gynecology

Volumn 109, Issue 6, 2007, Pages 1421-1423

  Mousa, Noha A ^b   Bedaiwy, Mohamed A ^a   Casper, Robert F ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE INHIBITOR; ESTRADIOL; EXEMESTANE; LETROZOLE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DISEASE SEVERITY; ENDOMETRIOSIS; FEMALE; FOLLOW UP; HOT FLUSH; HUMAN; HYSTERECTOMY; PELVIS PAIN SYNDROME; PRIORITY JOURNAL; SALPINGOOOPHORECTOMY; TREATMENT DURATION; TREATMENT OUTCOME;

ANDROSTADIENES; AROMATASE INHIBITORS; CHRONIC DISEASE; ENDOMETRIOSIS; ESTROGEN REPLACEMENT THERAPY; FEMALE; HOT FLASHES; HUMANS; HYSTERECTOMY; MIDDLE AGED; NITRILES; PELVIC PAIN; POSTMENOPAUSE; TREATMENT OUTCOME; TRIAZOLES;

EID: 34249901288     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000265807.19397.6d     Document Type: Article

References (22)

1. Mounsey AL, Wilgus A, Slawson DC. Diagnosis and management of endometriosis. Am Fam Physician 2006;74:594-600.
2. Beuke M, Dahlem R, Fisch M. Distal stenosis of the ureter due to extrinsic endometriosis in a postmenopausal woman [in German]. Aktuelle Urol 2006;37:143-4.
3. Nikolov A, Dimitrov A, Iliev D, Genov N. Endometriosis during postmenopausal period - probable causes for its origin and development [in Bulgarian]. Akush Ginekol (Sofiia) 2004;43:50-3.
4. Huntington A, Gilmour JA. A life shaped by pain: women and endometriosis. J Clin Nurs 2005;14:1124-32.
5. Vercellini P, Fedele L, Aimi G, Pietropaolo G, Consonni D, Crosignani PG. Association between endometriosis stage, lesion type, patient characteristics and severity of pelvic pain symptoms: a multivariate analysis of over 1000 patients. Hum Reprod 2007;22:266-71.
6. Porpora MG, Koninckx PR, Piazze J, Natili M, Colagrande S, Cosmi EV. Correlation between endometriosis and pelvic pain. J Am Assoc Gynecol Laparosc 1999;6:429-34.
7. Mitwally MF, Gotlieb L, Casper RF. Prevention of bone loss and hypoestrogenic symptoms by estrogen and interrupted progestogen add-back in long-term GnRH-agonist down-regulated patients with endometriosis and premenstrual syndrome. Menopause 2002;9:236-41.
8. Bedaiwy MA, Casper RF. Treatment with leuprolide acetate and hormonal add-back for up to 10 years in stage IV endometriosis patients with chronic pelvic pain. Fertil Steril 2006;86:220-2.
9. Abbott JA, Hawe J, Clayton RD, Garry R. The effects and effectiveness of laparoscopic excision of endometriosis: a prospective study with 2-5 year follow-up. Hum Reprod 2003;18:1922-7.
10. Zullo F, Palomba S, Zupi E, Russo T, Morelli M, Sena T, et al. Long-term effectiveness of presacral neurectomy for the treatment of severe dysmenorrhea due to endometriosis. J Am Assoc Gynecol Laparosc 2004;11:23-8.
11. Kapural L, Narouze SN, Janicki TI, Mekhail N. Spinal cord stimulation is an effective treatment for the chronic intractable visceral pelvic pain. Pain Med 2006;7:440-3.
12. Hansen KA, Eyster KM. A review of current management of endometriosis in 2006: an evidence-based approach. S D Med 2006;59:153-9.
13. Toki T, Horiuchi A, Li SF, Nakayama K, Silverberg SG, Fujii S. Proliferative activity of postmenopausal endometriosis: a histopathologic and immunocytochemical study. Int J Gynecol Pathol 1996;15:45-53.
14. Attar E, Bulun SE. Aromatase inhibitors: the next generation of therapeutics for endometriosis? Fertil Steril 2006;85:1307-18.
15. Velasco I, Rueda J, Acien P. Aromatase expression in endometriotic tissues and cell cultures of patients with endometriosis. Mol Hum Reprod 2006;12:377-81.
16. Winer EP, Hudis C, Burstein HJ, Chlebowski RT, Ingle JN, Edge SB, et al. American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for women with hormone receptor-positive breast cancer: status report 2002. J Clin Oncol 2002;20:3317-27.
17. Mauras N, Lima J, Patel D, Rini A, di Salle E, Kwok A, et al. Pharmacokinetics and dose finding of a potent aromatase inhibitor, Aromasin (exemestane), in young males [published erratum appears in J Clin Endocrinol Metab 2004 Feb;89:732]. J Clin Endocrinol Metab 2003;88:5951-6.
18. Goss PE, Qi S, Cheung AM, Hu H, Mendes M, Pritzker KP. Effects of the steroidal aromatase inhibitor exemestane and the nonsteroidal aromatase inhibitor letrozole on bone and lipid metabolism in ovariectomized rats. Clin Cancer Res 2004;10:5717-23.
19. Buzdar AU, Robertson JF, Eiermann W, Nabholtz JM. An overview of the pharmacology and pharmacokinetics of the newer generation aromatase inhibitors anastrozole, letrozole, and exemestane. Cancer 2002;95:2006-16.
20. Janicke F. Are all aromatase inhibitors the same? A review of the current evidence. Breast 2004;13 suppl:10-8.
21. Fatemi HM, Al-Turki HA, Papanikolaou EG, Kosmas L, De Sutter P, Devroey P. Successful treatment of an aggressive recurrent post-menopausal endometriosis with an aromatase inhibitor. Reprod Biomed Online 2005;11:455-7.
22. Ailawadi RK, Jobanputra S, Kataria M, Gurates B, Bulun SE. Treatment of endometriosis and chronic pelvic pain with letrozole and norethindrone acetate: a pilot study. Fertil Steril 2004;81:290-6.